J G Hickman

Summary

Publications

  1. ncbi Human dermal safety studies with eflornithine HCl 13.9% cream (Vaniqa), a novel treatment for excessive facial hair
    J G Hickman
    Education and Research Foundation Inc, 2602 Langhorne Road, VA 24501, USA
    Curr Med Res Opin 16:235-44. 2001

Detail Information

Publications1

  1. ncbi Human dermal safety studies with eflornithine HCl 13.9% cream (Vaniqa), a novel treatment for excessive facial hair
    J G Hickman
    Education and Research Foundation Inc, 2602 Langhorne Road, VA 24501, USA
    Curr Med Res Opin 16:235-44. 2001
    ..It can cause irritation under exaggerated conditions of use. Eflornithine HCl 13.9% cream, therefore, has a favourable dermal safety profile appropriate for a topical treatment to be applied routinely...